BRCA1 expression is repressed through promoter hypermethylation in 11–31% of breast, 5–15% of ovarian cancer and about 60% of pancreatic ductal carcinoma (Catteau and Morris, 2002; Peng et al, 2006). Here, BRCA1 is linked to ovarian cancer.